<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34035524</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2522-5812</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nature metabolism</Title><ISOAbbreviation>Nat Metab</ISOAbbreviation></Journal><ArticleTitle>Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>774</StartPage><EndPage>785</EndPage><MedlinePgn>774-785</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42255-021-00407-6</ELocationID><Abstract><AbstractText>Patients with coronavirus disease 2019 (COVID-19) are reported to have a greater prevalence of hyperglycaemia. Cytokine release as a consequence of severe acute respiratory syndrome coronavirus 2 infection may precipitate the onset of metabolic alterations by affecting glucose homeostasis. Here we describe abnormalities in glycometabolic control, insulin resistance and beta cell function in patients with COVID-19 without any pre-existing history or diagnosis of diabetes, and document glycaemic abnormalities in recovered patients 2 months after onset of disease. In a cohort of 551 patients hospitalized for COVID-19 in Italy, we found that 46% of patients were hyperglycaemic, whereas 27% were normoglycaemic. Using clinical assays and continuous glucose monitoring in a subset of patients, we detected altered glycometabolic control, with insulin resistance and an abnormal cytokine profile, even in normoglycaemic patients. Glycaemic abnormalities can be detected for at least 2 months in patients who recovered from COVID-19. Our data demonstrate that COVID-19 is associated with aberrant glycometabolic control, which can persist even after recovery, suggesting that further investigation of metabolic abnormalities in the context of long COVID is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Montefusco</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ben Nasr</LastName><ForeName>Moufida</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1022-7853</Identifier><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>D'Addio</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loretelli</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7583-8540</Identifier><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastore</LastName><ForeName>Ida</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0164-3772</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniele</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Metabolic Diseases, Department of Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelsalam</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3920-4716</Identifier><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maestroni</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dell'Acqua</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology, Aziende Socio Sanitarie Territoriali Fatebenefratelli Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ippolito</LastName><ForeName>Elio</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3770-7205</Identifier><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assi</LastName><ForeName>Emma</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9363-4234</Identifier><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usuelli</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seelam</LastName><ForeName>Andy Joe</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-4211-5485</Identifier><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiorina</LastName><ForeName>Roberta Maria</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chebat</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morpurgo</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunati</LastName><ForeName>Maria Elena</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolla</LastName><ForeName>Andrea Mario</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finzi</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pathology, University Hospital ASST-Settelaghi, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdi</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Renal Division and Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonventre</LastName><ForeName>Joseph V</ForeName><Initials>JV</Initials><Identifier Source="ORCID">0000-0001-7144-386X</Identifier><AffiliationInfo><Affiliation>Renal Division and Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusconi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0375-9990</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riva</LastName><ForeName>Agostino</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3171-3049</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corradi</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8836-4778</Identifier><AffiliationInfo><Affiliation>Department of Biomedical, Biotechnological and Translational Sciences, Unit of Pathology, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santus</LastName><ForeName>Pierachille</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, DIBIC, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nebuloni</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2773-734X</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folli</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolism, Department of Health Science, Universit&#xe0; di Milano, ASST Santi Paolo e Carlo, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuccotti</LastName><ForeName>Gian Vincenzo</ForeName><Initials>GV</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital Buzzi, Universit&#xe0; di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiorina</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1093-7724</Identifier><AffiliationInfo><Affiliation>Division of Endocrinology, ASST Fatebenefratelli-Sacco, Milan, Italy. paolo.fiorina@childrens.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, DIBIC, Universit&#xe0; di Milano, Milan, Italy. paolo.fiorina@childrens.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nephrology Division, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. paolo.fiorina@childrens.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K24 AI116925</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 DK039773</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Nat Metab</MedlineTA><NlmUniqueID>101736592</NlmUniqueID><ISSNLinking>2522-5812</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Endocrinol. 2021 Aug;17(8):448. doi: 10.1038/s41574-021-00526-w</RefSource><PMID Version="1">34127837</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006943" MajorTopicYN="N">Hyperglycemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050417" MajorTopicYN="N">Insulin-Secreting Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34035524</ArticleId><ArticleId IdType="mid">NIHMS1865393</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pii">10.1038/s42255-021-00407-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xu B, Kraemer MUG &amp; Open, C.-D. C. G. Open access epidemiological data from the COVID-19 outbreak. Lancet Infect Dis 20, 534, doi:10.1016/S1473-3099(20)30119-5 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30119-5</ArticleId><ArticleId IdType="pmc">PMC7158984</ArticleId><ArticleId IdType="pubmed">32087115</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, Renia L, MacAry PA &amp; Ng LFP The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20, 363&#x2013;374, doi:10.1038/s41577-020-03118 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-03118</ArticleId><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P &amp; Shi ZL Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol, doi:10.1038/s41579-020-00459-7 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng SQ &amp; Peng HJ Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China. J Clin Med 9, doi:10.3390/jcm9020575 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020575</ArticleId><ArticleId IdType="pmc">PMC7074453</ArticleId><ArticleId IdType="pubmed">32093211</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507&#x2013;513, doi:10.1016/S01406736(20)30211-7 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S01406736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadini GP, Morieri ML, Longato E &amp; Avogaro A Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest 43, 867&#x2013;869, doi:10.1007/s40618-020-01236-2 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01236-2</ArticleId><ArticleId IdType="pmc">PMC7103097</ArticleId><ArticleId IdType="pubmed">32222956</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JK et al. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med 23, 623&#x2013;628, doi:10.1111/j.1464-5491.2006.01861.x (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-5491.2006.01861.x</ArticleId><ArticleId IdType="pubmed">16759303</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JK, Lin SS, Ji XJ &amp; Guo LM Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 47, 193&#x2013;199, doi:10.1007/s00592-009-0109-4 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-009-0109-4</ArticleId><ArticleId IdType="pmc">PMC7088164</ArticleId><ArticleId IdType="pubmed">19333547</ArticleId></ArticleIdList></Reference><Reference><Citation>Apicella M et al. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol 8, 782&#x2013;792, doi:10.1016/S2213-8587(20)30238-2 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30238-2</ArticleId><ArticleId IdType="pmc">PMC7367664</ArticleId><ArticleId IdType="pubmed">32687793</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, et al. Beta-cells from patients with COVID-19 and from isolated human islets exhibit ACE2, DPP4, and TMPRSS2 expression, viral infiltration and necroptotic cell death. Research Square [preprint], doi:DOI:10.21203/rs.3.rs-88524/v1 (Oct 2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-88524/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusmartseva I et al. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19. Cell Metab 32, 1041&#x2013;1051 e1046, doi:10.1016/j.cmet.2020.11.005 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC7664515</ArticleId><ArticleId IdType="pubmed">33207244</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L et al. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Cell Stem Cell 27, 125&#x2013;136 e127, doi:10.1016/j.stem.2020.06.015 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7303620</ArticleId><ArticleId IdType="pubmed">32579880</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F et al. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clin Gastroenterol Hepatol 18, 2128&#x2013;2130 e2122, doi:10.1016/j.cgh.2020.04.040 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.040</ArticleId><ArticleId IdType="pmc">PMC7194639</ArticleId><ArticleId IdType="pubmed">32334082</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 203, 622&#x2013;630, doi:10.1002/path.1560 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1560</ArticleId><ArticleId IdType="pmc">PMC7167761</ArticleId><ArticleId IdType="pubmed">15141376</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller JA et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab 3, 149&#x2013;165, doi:10.1038/s42255-021-00347-1 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00347-1</ArticleId><ArticleId IdType="pubmed">33536639</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein SR et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 8, 546&#x2013;550, doi:10.1016/S2213-8587(20)30152-2 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30152-2</ArticleId><ArticleId IdType="pmc">PMC7180013</ArticleId><ArticleId IdType="pubmed">32334646</ArticleId></ArticleIdList></Reference><Reference><Citation>Dungan KM, Braithwaite SS &amp; Preiser JC Stress hyperglycaemia. Lancet 373, 1798&#x2013;1807, doi:10.1016/S0140-6736(09)60553-5 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60553-5</ArticleId><ArticleId IdType="pmc">PMC3144755</ArticleId><ArticleId IdType="pubmed">19465235</ArticleId></ArticleIdList></Reference><Reference><Citation>Dave GS &amp; Kalia K Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. Cell Mol Biol (Noisy-le-grand) 53, 68&#x2013;78 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17543235</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho Vidigal F, Guedes Cocate P, Goncalves Pereira L &amp; de Cassia Goncalves Alfenas R The role of hyperglycemia in the induction of oxidative stress and inflammatory process. Nutr Hosp 27, 1391&#x2013;1398, doi:10.3305/nh.2012.27.5.5917 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.3305/nh.2012.27.5.5917</ArticleId><ArticleId IdType="pubmed">23478683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri A et al. Stress Hyperglycemia and Mortality in Subjects With Diabetes and Sepsis. Crit Care Explor 2, e0152, doi:10.1097/CCE.0000000000000152 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000152</ArticleId><ArticleId IdType="pmc">PMC7365708</ArticleId><ArticleId IdType="pubmed">32766552</ArticleId></ArticleIdList></Reference><Reference><Citation>Niewczas MA et al. A signature of circulating inflammatory proteins and development of endstage renal disease in diabetes. Nat Med 25, 805&#x2013;813, doi:10.1038/s41591-019-0415-5 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0415-5</ArticleId><ArticleId IdType="pmc">PMC6508971</ArticleId><ArticleId IdType="pubmed">31011203</ArticleId></ArticleIdList></Reference><Reference><Citation>Folli F et al. Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients&#x2019; skin which are normalized by kidney-pancreas transplantation. PLoS One 5, e9923, doi:10.1371/journal.pone.0009923 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009923</ArticleId><ArticleId IdType="pmc">PMC2848014</ArticleId><ArticleId IdType="pubmed">20360867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi R &amp; Fiorina P Impact of islet transplantation on diabetes complications and quality of life. Curr Diab Rep 11, 355&#x2013;363, doi:10.1007/s11892-011-0211-1 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-011-0211-1</ArticleId><ArticleId IdType="pubmed">21748256</ArticleId></ArticleIdList></Reference><Reference><Citation>La Rocca E et al. Patient survival and cardiovascular events after kidney-pancreas transplantation: comparison with kidney transplantation alone in uremic IDDM patients. Cell Transplant 9, 929&#x2013;932, doi:10.1177/096368970000900621 (2000).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096368970000900621</ArticleId><ArticleId IdType="pubmed">11202580</ArticleId></ArticleIdList></Reference><Reference><Citation>Introduction: Standards of Medical Care in Diabetes-2020. Diabetes Care 43, S1&#x2013;S2, doi:10.2337/dc20-Sint (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-Sint</ArticleId><ArticleId IdType="pubmed">31862741</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar SS et al. Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of beta-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series. Diabetes Care 39, 1602&#x2013;1613, doi:10.2337/dc15-0931 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc15-0931</ArticleId><ArticleId IdType="pmc">PMC5001146</ArticleId><ArticleId IdType="pubmed">27407117</ArticleId></ArticleIdList></Reference><Reference><Citation>Erion K &amp; Corkey BE beta-Cell Failure or beta-Cell Abuse? Front Endocrinol (Lausanne) 9, 532, doi:10.3389/fendo.2018.00532 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00532</ArticleId><ArticleId IdType="pmc">PMC6146038</ArticleId><ArticleId IdType="pubmed">30271382</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir GC &amp; Bonner-Weir S Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53 Suppl 3, S16&#x2013;21, doi:10.2337/diabetes.53.suppl_3.s16 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.53.suppl_3.s16</ArticleId><ArticleId IdType="pubmed">15561905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Jiang M, Chen X &amp; Montaner LJ Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol 108, 17&#x2013;41, doi:10.1002/JLB.3COVR0520-272R (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3COVR0520-272R</ArticleId><ArticleId IdType="pmc">PMC7323250</ArticleId><ArticleId IdType="pubmed">32534467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L &amp; Song J Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46, 846&#x2013;848, doi:10.1007/s00134-020-05991-x (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaninov N In the eye of the COVID-19 cytokine storm. Nat Rev Immunol 20, 277, doi:10.1038/s41577-020-0305-6 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0305-6</ArticleId><ArticleId IdType="pmc">PMC7132547</ArticleId><ArticleId IdType="pubmed">32249847</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033&#x2013;1034, doi:10.1016/S0140-6736(20)30628-0 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Solerte SB, Di Sabatino A, Galli M &amp; Fiorina P Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19. Acta Diabetol 57, 779&#x2013;783, doi:10.1007/s00592-020-01539-z (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-020-01539-z</ArticleId><ArticleId IdType="pmc">PMC7275134</ArticleId><ArticleId IdType="pubmed">32506195</ArticleId></ArticleIdList></Reference><Reference><Citation>Solerte SB et al. Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study. Diabetes Care, doi:10.2337/dc20-1521 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-1521</ArticleId><ArticleId IdType="pmc">PMC7770266</ArticleId><ArticleId IdType="pubmed">32994187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollstein T et al. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab 2, 1021&#x2013;1024, doi:10.1038/s42255-020-00281-8 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00281-8</ArticleId><ArticleId IdType="pubmed">32879473</ArticleId></ArticleIdList></Reference><Reference><Citation>Naguib MN, et al. New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19. J Pediatr Endocrinol Metab, doi:10.1515/jpem-2020-0426 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpem-2020-0426</ArticleId><ArticleId IdType="pubmed">33180050</ArticleId></ArticleIdList></Reference><Reference><Citation>Obukhov AG et al. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes. Diabetes 69, 1875&#x2013;1886, doi:10.2337/dbi20-0019 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dbi20-0019</ArticleId><ArticleId IdType="pmc">PMC7458035</ArticleId><ArticleId IdType="pubmed">32669391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C et al. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes Care 43, 1408&#x2013;1415, doi:10.2337/dc20-0723 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0723</ArticleId><ArticleId IdType="pmc">PMC7305003</ArticleId><ArticleId IdType="pubmed">32430456</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole SA, Laviada-Molina HA, Serres-Perales JM, Rodriguez-Ayala E &amp; Bastarrachea RA The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins? Pathogens 9, doi:10.3390/pathogens9050389 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9050389</ArticleId><ArticleId IdType="pmc">PMC7281197</ArticleId><ArticleId IdType="pubmed">32438687</ArticleId></ArticleIdList></Reference><Reference><Citation>Krogvold L et al. Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64, 1682&#x2013;1687, doi:10.2337/db14-1370 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1370</ArticleId><ArticleId IdType="pubmed">25422108</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH et al. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 63, 446&#x2013;455, doi:10.2337/db13-0619 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-0619</ArticleId><ArticleId IdType="pubmed">23974921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS Inflammation, metaflammation and immunometabolic disorders. Nature 542, 177&#x2013;185, doi:10.1038/nature21363 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21363</ArticleId><ArticleId IdType="pubmed">28179656</ArticleId></ArticleIdList></Reference><Reference><Citation>Monroy A et al. Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans. Diabetologia 52, 2169&#x2013;2181, doi:10.1007/s00125-009-1451-3 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-009-1451-3</ArticleId><ArticleId IdType="pmc">PMC2845986</ArticleId><ArticleId IdType="pubmed">19633828</ArticleId></ArticleIdList></Reference><Reference><Citation>Joya-Galeana J et al. Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects. Diabetes Metab Res Rev 27, 373&#x2013;382, doi:10.1002/dmrr.1185 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.1185</ArticleId><ArticleId IdType="pmc">PMC4416699</ArticleId><ArticleId IdType="pubmed">21309063</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFronzo RA Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35, 389&#x2013;397, doi:10.1007/BF00401208 (1992).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00401208</ArticleId><ArticleId IdType="pubmed">1516769</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F et al. A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. Diabetes 49, 2126&#x2013;2134, doi:10.2337/diabetes.49.12.2126 (2000).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.49.12.2126</ArticleId><ArticleId IdType="pubmed">11118016</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzban L New insights into the mechanisms of islet inflammation in type 2 diabetes. Diabetes 64, 1094&#x2013;1096, doi:10.2337/db14-1903 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1903</ArticleId><ArticleId IdType="pubmed">25805760</ArticleId></ArticleIdList></Reference><Reference><Citation>Donath MY, Boni-Schnetzler M, Ellingsgaard H, Halban PA &amp; Ehses JA Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol Metab 21, 261&#x2013;267, doi:10.1016/j.tem.2009.12.010 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2009.12.010</ArticleId><ArticleId IdType="pubmed">20096598</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher MJ et al. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia 57, 491&#x2013;501, doi:10.1007/s00125-013-3116-5 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-013-3116-5</ArticleId><ArticleId IdType="pmc">PMC3966210</ArticleId><ArticleId IdType="pubmed">24429578</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi K &amp; Nagai R Islet inflammation in type 2 diabetes and physiology. J Clin Invest 127, 14&#x2013;23, doi:10.1172/JCI88877 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI88877</ArticleId><ArticleId IdType="pmc">PMC5199688</ArticleId><ArticleId IdType="pubmed">28045399</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone JH et al. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med, doi:10.1056/NEJMoa2028836 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2028836</ArticleId><ArticleId IdType="pmc">PMC7646626</ArticleId><ArticleId IdType="pubmed">33085857</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Addio F et al. Islet transplantation stabilizes hemostatic abnormalities and cerebral metabolism in individuals with type 1 diabetes. Diabetes Care 37, 267&#x2013;276, doi:10.2337/dc13-1663 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc13-1663</ArticleId><ArticleId IdType="pmc">PMC3867995</ArticleId><ArticleId IdType="pubmed">24026546</ArticleId></ArticleIdList></Reference><Reference><Citation>Astorri E, Fiorina P, Gavaruzzi G, Astorri A &amp; Magnati G Left ventricular function in insulin-dependent and in non-insulin-dependent diabetic patients: radionuclide assessment. Cardiology 88, 152&#x2013;155, doi:10.1159/000177322 (1997).</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000177322</ArticleId><ArticleId IdType="pubmed">9096915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind M et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA 317, 379&#x2013;387, doi:10.1001/jama.2016.19976 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.19976</ArticleId><ArticleId IdType="pubmed">28118454</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S et al. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med, doi:10.1001/jamainternmed.2020.3596 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3596</ArticleId><ArticleId IdType="pmc">PMC7364338</ArticleId><ArticleId IdType="pubmed">32667668</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 323, 2052&#x2013;2059, doi:10.1001/jama.2020.6775 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino TV et al. Exenatide regulates pancreatic islet integrity and insulin sensitivity in the nonhuman primate baboon Papio hamadryas. JCI Insight 4, doi:10.1172/jci.insight.93091 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.93091</ArticleId><ArticleId IdType="pmc">PMC6824445</ArticleId><ArticleId IdType="pubmed">31536476</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniele G et al. The inflammatory status score including IL-6, TNF-alpha, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 51, 123&#x2013;131, doi:10.1007/s00592-013-0543-1 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-013-0543-1</ArticleId><ArticleId IdType="pubmed">24370923</ArticleId></ArticleIdList></Reference><Reference><Citation>Roder ME et al. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Diabetes Care 22, 609&#x2013;614, doi:10.2337/diacare.22.4.609 (1999).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.22.4.609</ArticleId><ArticleId IdType="pubmed">10189540</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews DR et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412&#x2013;419, doi:10.1007/BF00280883 (1985).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00280883</ArticleId><ArticleId IdType="pubmed">3899825</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandle M, Lehmann R, Maly FE, Schmid C &amp; Spinas GA Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes Care 24, 1253&#x2013;1258, doi:10.2337/diacare.24.7.1253 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.24.7.1253</ArticleId><ArticleId IdType="pubmed">11423511</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>